We are live on
!
Find out more
State Street SPDR S&P Biotech ETF
458 hedge funds and large institutions have $7.41B invested in State Street SPDR S&P Biotech ETF in 2020 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 151 increasing their positions, 148 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% less funds holding
Funds holding: 474 → 458 (-16)
13% less first-time investments, than exits
New positions opened: 68 | Existing positions closed: 78
61% less call options, than puts
Call options by funds: $650M | Put options by funds: $1.68B
Holders
458
Holding in Top 10
15
Calls
$650M
Puts
$1.68B
Top Buyers
| 1 | +$864M | |
| 2 | +$665M | |
| 3 | +$589M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$307M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$226M |
Top Sellers
| 1 | -$268M | |
| 2 | -$208M | |
| 3 | -$118M | |
| 4 |
Two Sigma Investments
New York
|
-$82.1M |
| 5 |
CAC
Cowen and Company
New York
|
-$35.4M |